Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study

Robert Flisiak, Dorota Zarębska-Michaluk, Aleksandra Berkan-Kawińska, Magdalena Tudrujek-Zdunek, Magdalena Rogalska, Anna Piekarska, Dorota Kozielewicz, Krzysztof Kłos, Marta Rorat, Beata Bolewska, Anna Szymanek-Pasternak, Włodzimierz Mazur, Beata Lorenc, Regina Podlasin, Katarzyna Sikorska, Barbara Oczko-Grzesik, Cezary Iwaszkiewicz, Bartosz Szetela, Paweł Pabjan, Małgorzata Pawłowska, Krzysztof Tomasiewicz, Joanna Polańska, Jerzy Jaroszewicz
doi: https://doi.org/10.1101/2020.10.30.20215301
Robert Flisiak
1Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: robert.flisiak1@gmail.com
Dorota Zarębska-Michaluk
2Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleksandra Berkan-Kawińska
3Department of Infectious Diseases and Hepatology, Medical University of Łódź, Łódź,Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magdalena Tudrujek-Zdunek
4Department of Infectious Diseases and Hepatology, Medical University of Lublin, Lublin, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magdalena Rogalska
1Department of Infectious Diseases and Hepatology, Medical University of Białystok, Białystok, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Piekarska
3Department of Infectious Diseases and Hepatology, Medical University of Łódź, Łódź,Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dorota Kozielewicz
5Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krzysztof Kłos
6Department of Infectious Diseases and Allergology, Military Institute of Medicine, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marta Rorat
7Department of Forensic Medicine, Wrocław Medical University, Wrocław, Poland
8First Infectious Diseases Ward, Gromkowski Regional Specialist Hospital in Wrocław, Wrocław, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beata Bolewska
9Department of Infectious Diseases, University of Medical Sciences, Poznań, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Szymanek-Pasternak
10Department of Infectious Diseases and Hepatology, Wrocław Medical University, Wrocław, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Włodzimierz Mazur
11Clinical Department of Infectious Diseases in Chorzów, Medical University of Silesia, Katowice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beata Lorenc
12Pomeranian Center of Infectious Diseases, Department of Infectious Diseases, Medical University of Gdańsk, Gdańsk, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Regina Podlasin
13Hospital of Infectious Diseases in Warsaw, Warsaw, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katarzyna Sikorska
14Department of Tropical Medicine and Epidemiology, Medical University of Gdańsk, Gdańsk Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Oczko-Grzesik
15Department of Infectious Diseases in Bytom, Medical University of Silesia, Katowice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cezary Iwaszkiewicz
16Department of Rheumatology and Osteoporosis, Jozef Strus Hospital in Poznań, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bartosz Szetela
17Department of Infectious Diseases, Liver Diseases and Acquired Immune Deficiencies, Wrocław Medical University, Wrocław, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paweł Pabjan
2Department of Infectious Diseases, Jan Kochanowski University, Kielce, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Małgorzata Pawłowska
5Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krzysztof Tomasiewicz
4Department of Infectious Diseases and Hepatology, Medical University of Lublin, Lublin, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Polańska
18Department of Data Science and Engineering, Silesian University of Technology, Gliwice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jerzy Jaroszewicz
15Department of Infectious Diseases in Bytom, Medical University of Silesia, Katowice, Poland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Remdesivir (RDV) is the only antiviral drug registered currently for treatment of COVID-19 after a few clinical trials with controversial results. The purpose of this study was to evaluate the effectiveness and safety of RDV in patients with COVID-19 in real world settings.

Methods Patients were selected from 1496 individuals included in the SARSTer national database; 122 of them received therapy with RDV and 211 were treated with lopinavir/ritonavir (LPV/r)-based therapy. The primary end-point of effectiveness was clinical improvement in the ordinal 8-point scale, which was defined as a 2-point decrease from baseline to 7, 14, 21 and 28 days of hospitalization. The secondary end-points of effectiveness included: death rate, rate of no clinical improvement within 28 days of hospitalization in the ordinal scale, rate of the need for constant oxygen therapy, duration of oxygen therapy, rate of the need for mechanical ventilation, total hospitalization time, and rate of positive RT PCR for SARS-CoV-2 after 30 days.

Findings Significantly higher rates of clinical improvement, by 15% and 10% respectively, were observed after RDV treatment compared to LPV/r at days 21 and 28. The difference between regimens increased with worsening of oxygen saturation (SpO2) and depending on the baseline score from the ordinal scale. Statistically significant differences supporting RDV were also noted regarding the rate of no clinical improvement within 28 days of hospitalization and hospitalization duration in patients with baseline SpO2 ≤90%. In the logistic regression model only the administration of remdesivir was independently associated with at least a 2-point improvement in the ordinal scale between baseline and day 21.

Interpretation In conclusion, data collected in this retrospective, observational, real world study supported use of remdesivir for treatment of SARS-CoV-2 infection particularly in patients with oxygen saturation ≤95%.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

SARSTer study is supported by Polskie Towarzystwo Epidemiologow i Lekarzy Chorob Zakaznych

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study is approved by the Ethical Committee of Medical University of Bialystok, Poland

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data referred can be provided by authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study
Robert Flisiak, Dorota Zarębska-Michaluk, Aleksandra Berkan-Kawińska, Magdalena Tudrujek-Zdunek, Magdalena Rogalska, Anna Piekarska, Dorota Kozielewicz, Krzysztof Kłos, Marta Rorat, Beata Bolewska, Anna Szymanek-Pasternak, Włodzimierz Mazur, Beata Lorenc, Regina Podlasin, Katarzyna Sikorska, Barbara Oczko-Grzesik, Cezary Iwaszkiewicz, Bartosz Szetela, Paweł Pabjan, Małgorzata Pawłowska, Krzysztof Tomasiewicz, Joanna Polańska, Jerzy Jaroszewicz
medRxiv 2020.10.30.20215301; doi: https://doi.org/10.1101/2020.10.30.20215301
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Remdesivir-based therapy improved recovery of patients with COVID-19 in the SARSTer multicentre, real-world study
Robert Flisiak, Dorota Zarębska-Michaluk, Aleksandra Berkan-Kawińska, Magdalena Tudrujek-Zdunek, Magdalena Rogalska, Anna Piekarska, Dorota Kozielewicz, Krzysztof Kłos, Marta Rorat, Beata Bolewska, Anna Szymanek-Pasternak, Włodzimierz Mazur, Beata Lorenc, Regina Podlasin, Katarzyna Sikorska, Barbara Oczko-Grzesik, Cezary Iwaszkiewicz, Bartosz Szetela, Paweł Pabjan, Małgorzata Pawłowska, Krzysztof Tomasiewicz, Joanna Polańska, Jerzy Jaroszewicz
medRxiv 2020.10.30.20215301; doi: https://doi.org/10.1101/2020.10.30.20215301

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (857)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8557)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1239)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10292)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1676)
  • Nursing (97)
  • Nutrition (249)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (101)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (248)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1765)
  • Public and Global Health (3835)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (166)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)